“The penalty is miniscule. Pay it. We will be able to see whether the trial succeeds by extrapolating to 293 and 390 and it allows other regulatory agencies to make a decision...”

I understand your thought process behind this, but I don’t see how a regulatory agency is going to approve leronlimab based on extrapolating a significant p value at 293 or 390 based on current data. Seems unlikely.